BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$0.84
+0.11 (+15.71%)
Open$0.68
Previous Close$0.72
Day High$0.85
Day Low$0.68
52W High$19.87
52W Low$0.60
Volume—
Avg Volume185.0K
Market Cap3.46M
P/E Ratio—
EPS$-1.65
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+808.5% upside
Current
$0.84
$0.84
Target
$7.59
$7.59
$6.77
$7.59 avg
$11.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.97M | 1.16M | 1.19M |
| Net Income | -7,905,336 | -117,803 | -121,826 |
| Profit Margin | -401.3% | -10.2% | -10.2% |
| EBITDA | -9,163,160 | -246,829 | -223,977 |
| Free Cash Flow | — | -166,595 | -168,575 |
| Rev Growth | — | +16.9% | +20.6% |
| Debt/Equity | — | 0.36 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.53 | -1.09% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $361.16 | +0.17% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.13 | -0.16% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $494.74 | -0.98% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $628.06 | -0.59% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $297.43 | +1.33% | 69.3 | 39.97B |